François Lallemand Selected Research

François Lallemand Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 07/2003
12	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2002
4	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2011
4	Carcinogenesis 01/2020 - 07/2015
3	Carcinoma (Carcinomatosis) 05/2020 - 07/2015
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 09/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 05/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019
1	Non-Muscle Invasive Bladder Neoplasms 10/2019
1	Triple Negative Breast Neoplasms 01/2018
1	Glioma (Gliomas) 09/2016
1	Neurofibrosarcoma (MPNST) 01/2014
1	Plexiform Neurofibroma 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2011
1	Poikiloderma of Kindler 09/2011
1	Atrophy 09/2011
1	Tetraploidy 02/2011
1	Aneuploidy (Aneuploid) 02/2011
1	Hepatocellular Carcinoma (Hepatoma) 07/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
5	Messenger RNA (mRNA)IBA 01/2020 - 02/2011
3	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 02/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Estrogens (Estrogen)FDA Link 05/2020 - 11/2002
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2015
2	WW Domain-Containing OxidoreductaseIBA 10/2018 - 05/2015
2	Estrogen ReceptorsIBA 07/2015 - 11/2002
2	Hormones (Hormone)IBA 07/2015 - 11/2002
2	Estradiol (Delestrogen)FDA LinkGeneric 07/2015 - 11/2002
2	matrigelIBA 09/2011 - 12/2010
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022
1	Dietary CholesterolIBA 01/2022
1	CholesterolIBA 01/2022
1	Forkhead Box Protein O1IBA 01/2020
1	Forkhead Box Protein O3IBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 10/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2018
1	Deferasirox FDA Link 01/2018
1	Chelating AgentsIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	IronIBA 01/2018
1	KynurenineIBA 01/2018
1	LigandsIBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	OsteopontinIBA 09/2016
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 03/2016
1	Long Noncoding RNAIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 07/2015
1	CateninsIBA 05/2015
1	Collagen Type I (Type I Collagen)IBA 09/2011
1	IntegrinsIBA 09/2011
1	Aurora Kinase AIBA 02/2011
1	von Willebrand FactorIBA 12/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2003
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 07/2003
1	CyclinsIBA 11/2002
1	Cyclin D1IBA 11/2002
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2002
1	Fulvestrant (Faslodex)FDA Link 11/2002

Therapy/Procedure

4	Therapeutics 05/2020 - 01/2014
3	Radiotherapy 01/2017 - 11/2015
2	Neoadjuvant Therapy 01/2021 - 11/2015
1	Operative Surgical Procedures 01/2021
1	Cystectomy 10/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Immunotherapy 01/2017